← 返回

口腔鳞状细胞癌中 CX3CL1 趋化因子和 CD57+淋巴细胞的表达分析及其与临床病理特征的相关性

英文原题:Expression and analysis of CX3CL1 chemokine and CD57+ lymphocytes in oral squamous cell carcinoma and their correlation with clinicopathologic features.

查看英文原题

Expression and analysis of CX3CL1 chemokine and CD57+ lymphocytes in oral squamous cell carcinoma and their correlation with clinicopathologic features.

PubMed 2023/04/05(内容时间) J Cancer Res Ther Q4 · IF 1.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

结论是 CX3CL1 和 CD57 可能是 OSCC 免疫监视中的重要参与者。对患者总生存期进行详细随访的进一步研究将有助于研究 CX3CL1 在 OSCC 中的诊断、预后和治疗作用。

研究思路结论见上方概要

CX3CL1对T细胞、单核细胞和CD57+NK 细胞表现出趋化作用,介导抗肿瘤免疫。CX3CL1的作用已在乳腺、肺、结肠、胰腺、前列腺等肿瘤中进行研究。本研究旨在了解CX3CL1在口腔鳞状细胞癌(OSCC)中的重要性及其与CD57+细胞的相关性。

对75例原发性OSCC进行分期和组织病理学分级,随后进行CX3CL1和CD57的免疫组织化学检测。采用Mann-Whitney U检验、Kruskal-Wallis检验、Post hoc Bonferroni检验和Pearson相关系数进行分析。

肿瘤细胞中CX3CL1评估在高表达者占62.66%,CD57标记指数(LI)在8.2-111.6的宽范围内变化。随着组织学分级增加,CX3CL1和CD57的表达均观察到统计学显著降低(分别为p = 0.021和0.038)。

展开英文摘要原文

INTRODUCTION: CX3CL1 exhibits chemoattraction for T-cells, monocytes, and CD57+ natural killer cells mediating antitumor immunity. The role of CX3CL1 has been studied in tumors of the breast, lung, colon, pancreas, prostate, etc. The current study was undertaken to understand the importance of CX3CL1 and its correlation with CD57+ cells in oral squamous cell carcinoma (OSCC). MATERIAL AND METHODS: Seventy-five primary OSCC were staged and histopathologically graded, followed by immunohistochemistry for CX3CL1 and CD57. Mann-Whitney U-test, Kruskal-Wallis test, Post hoc Bonferroni test, and Pearson's correlation coefficient were applied. RESULTS: CX3CL1 assessment within the tumor cells was high in 62.66% of cases, and the CD57 Labeling Index (LI) varied over a wide range of 8.2-111.6. A statistically significant reduction in expression of both CX3CL1 and CD57 was observed with an increase in histologic grade (p = 0.021 and 0.038, respectively). DISCUSSION: It is concluded that CX3CL1 and CD57 may be important players in the immune surveillance of OSCC. Further studies with detailed follow-up for the overall survival of patients will help in studying the diagnostic, prognostic, and therapeutic roles of CX3CL1 in OSCC.

论文信息

作者
Singh S、Urs AB、Kumar P
第一作者单位
Department of Radiation Oncology, Maulana Azad Medical College, New Delhi, India.India
通讯作者单位
Department of Oral Pathology and Microbiology, Maulana Azad Medical College, New Delhi, India.India
期刊
Journal of cancer research and therapeutics2024 Apr 1
原文标识
PubMed 39023581 · DOI 10.4103/jcrt.jcrt_79_22